Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.
Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese MC, Simonetti I, Catalano O, Gabelloni M, Pradella S, Danti G, Flammia F, Borgheresi A, Agostini A, Bruno F, Palumbo P, Ottaiano A, Izzo F, Giovagnoni A, Barile A, Gandolfo N, Miele V.
Granata V, et al.
Biology (Basel). 2023 Jan 29;12(2):213. doi: 10.3390/biology12020213.
Biology (Basel). 2023.
PMID: 36829492
Free PMC article.
Review.
For several at-risk patients, such as those suffering from primary sclerosing cholangitis or fibropolycystic liver disease, the use of periodic (6-12 months) imaging of the liver by ultrasound (US), magnetic Resonance Imaging (MRI)/cholangiopancreatography (MRCP), or compu …
For several at-risk patients, such as those suffering from primary sclerosing cholangitis or fibropolycystic liver disease, the use of perio …